CLOSE

Dialog Box

Loading...

Clinical Trials 

Clinical trials are an essential part of the development of new treatments and help to improve the diagnosis, treatment and management of people with cancer.

RCA provides information about clinical trial registries and individual clinical trials with the hope that it assists you to be informed about what clinical trials are available. However, RCA is not responsible for the content or maintenance of these sites or specific clinical trial information. We will endeavor to keep this information up to date but the reader is ultimately responsible to check the accuracy of this information.

RCA neither recommends nor endorses any clinical trials. Patients are encouraged to complete their own research into any clinical trials and possible effects and impacts to their health as a result of such trials. It is the patient’s responsibility, in consultation with their medical professional, to determine whether they wish to take part in such trials.
 
Before you consider participation in any clinical trial you should seek advice from your medical professional. 

Clinical Trial Registries

Clinical trial registries allow you to find clinical trials in Australia. A registry is defined as an organisation or website that either:

  • Lists clinical trials being conducted (or that have recently been conducted) in Australia (or internationally, including Australia)
  • Provides a mechanism for patients or others to register their interest in participating in an Australian clinical trial
  • Provides a link between potential participants and Australian clinical trials.

For Clinical Trial Registries please visit australianclinicaltrials.gov.au.

Other clinical trial registries can be found by visiting these links:

http://www.australiancancertrials.gov.au/
http://www.cancervic.org.au/trials/
http://www.cancertrialsaustralia.com/
http://www.anzctr.org.au/

Other Clinical Trials

From time to time RCA is approached by clinicians who are involved with a clinical trial to share relevant information with the patient community. Details of these trials with contact information are below.

Trial Name: ACTICCA-1: Adjuvant chemotherapy with gemcitabine and cisplatin compared to observation after curative intent resection of cholangiocarcinoma and muscle invasive gall bladder carcinoma (ACTRN12615001283561) 
Locations:      Royal Brisbane and Women's Hospital, Queensland
                        The Townsville Hospital, Queensland
                        Nepean Hospital, New South Wales
                        Calvary Mater Newcastle Hospital, New South Wales
                        Bankstown-Lidcombe Hospital, New South Wales
                        Sir Charles Gairdner Hospital, Western Australia
Contact:
acticca1@ctc.usyd.edu.au
For further locations and additional information, please click here

Trial Name: A parallel group randomised, controlled, multi-centre phase II open label trial with two cohorts testing the combination of capecitabine and temozolomide (CAPTEM) and peptide receptor radionuclide therapy (PRRT) for the treatment of advanced pancreatic or midgut neuroendocrine tumours that are not suitable for surgery.  (ACTRN12615000909527)
Contact: controlnets@ctc.usyd.edu.au

Trial Name: A Phase II Trial of Ipilimumab and Nivolumab for the Treatment of Rare Cancers (NCT02923934)
Location: Olivia Newton John Cancer Research Centre, Heidelberg, Victoria
Contact: Teresa.Morgan@onjcri.org.au

Trial Name: NABNEC - A Randomised Phase II Study Of nab-paclitaxel In Combination With Carboplatin As First Line Treatment Of Gastrointestinal Neuroendocrine Carcinomas (ACTRN12616000958482)
Locations:       Royal North Shore Hospital, St Leonards, New South Wales
                         Westmead Hospital, Westmead, New South Wales
                         Calvary Mater Newcastle Hospital, Newcastle, New South Wales
                         Monash Medical Centre, Moorabbin, Victoria
                         Fiona Stanley Hospital, Murdoch, Western Australia
                         Royal Hobart Hospital, Hobart, Tasmania
Contact: Dr Mustafa Khasraw nabnec@ctc.usyd.edu.au 
For further locations, additional information and contact details, please click here

Trial Name: InterAACT - An International Multicentre Open Label Randomised Phase II Advanced Anal Cancer Trial Comparing Cisplatin plus 5-fluorouracil versus Carboplatin plus Weekly Paclitaxel in Patients with Inoperable Locally Recurrent or Metastatic Disease) (ACTRN12616000061437)
Location: Flinders Medical Centre - Bedford Park, South Australia
Contact: Dr Amitesh C Roy - interAACT@ctc.usyd.edu.au
For further locations, additional information and contact details, please click here

Trial Name: A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK525762 in Subjects With NUT Midline Carcinoma (NMC) and Other Cancers (NCT01587703) 
Location: Clayton, Victoria, 3168
Contact: arun.azad@monash.edu

Trial Name: AN OPEN-LABEL, MULTICENTRE, GLOBAL PHASE 2 BASKET STUDY OF ENTRECTINIB FOR THE TREATMENT OF PATIENTS WITH LOCALY ADVANCED OR METASTATIC SOLID TUMORS THAT HARBOR NTRK 1/2/3, ROS1, OR ALK GENE REARRANGEMENTS.
Location: Border Medical Oncolgy Albury, New South Wales
Contact: dlong@bordermedonc.com.au
For further locations and contact details, please click here